Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Janowsky

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervationK A Neve, R L Neve, S Fidel, et al.
Journal of Neurochemistry|November 1, 1996
Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapsesC K Meshul, G L Bunker, J N Mason, et al.
Synapse (New York, N.Y.)|August 15, 1998
[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated effluxR A Johnson, A J Eshleman, T Meyers, et al.
Journal of Neurochemistry|April 1, 1986
Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complexA Janowsky, P Berger, F Vocci, et al.
Journal of Medicinal Chemistry|October 1, 1988
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptorsT de Paulis, A Janowsky, R M Kessler, et al.
European Journal of Pharmacology|January 22, 1985
The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptakeA Janowsky, M M Schweri, P Berger, et al.
European Journal of Pharmacology|January 2, 1985
[3H]GBR-12935: a specific high affinity ligand for labeling the dopamine transport complexP Berger, A Janowsky, F Vocci, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell typeA J Eshleman, M Carmolli, M Cumbay, et al.
Science (New York, N.Y.)|November 26, 1982
Role of serotonergic input in the regulation of the beta-adrenergic receptor-coupled adenylate cyclase systemA Janowsky, F Okada, D H Manier, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapineA Janowsky, K A Neve, J M Kinzie, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1991
Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervationK A Neve, R L Neve, S Fidel, et al.
Journal of Neurochemistry|November 1, 1996
Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapsesC K Meshul, G L Bunker, J N Mason, et al.
Synapse (New York, N.Y.)|August 15, 1998
[3H]substrate- and cell-specific effects of uptake inhibitors on human dopamine and serotonin transporter-mediated effluxR A Johnson, A J Eshleman, T Meyers, et al.
Journal of Neurochemistry|April 1, 1986
Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complexA Janowsky, P Berger, F Vocci, et al.
Journal of Medicinal Chemistry|October 1, 1988
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptorsT de Paulis, A Janowsky, R M Kessler, et al.
European Journal of Pharmacology|January 22, 1985
The effects of surgical and chemical lesions on striatal [3H]threo-(+/-)-methylphenidate binding: correlation with [3H]dopamine uptakeA Janowsky, M M Schweri, P Berger, et al.
European Journal of Pharmacology|January 2, 1985
[3H]GBR-12935: a specific high affinity ligand for labeling the dopamine transport complexP Berger, A Janowsky, F Vocci, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell typeA J Eshleman, M Carmolli, M Cumbay, et al.
Science (New York, N.Y.)|November 26, 1982
Role of serotonergic input in the regulation of the beta-adrenergic receptor-coupled adenylate cyclase systemA Janowsky, F Okada, D H Manier, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapineA Janowsky, K A Neve, J M Kinzie, et al.
Pageof 6